MRI-based radiomics analysis in differentiating solid non-small-cell from small-cell lung carcinoma: a pilot study.

S Dang1, Y Guo1, D Han1

  • 1Department of Radiology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China.

Clinical Radiology
|July 11, 2022
PubMed
Summary

A T2-weighted MRI radiomics signature can help differentiate non-small-cell lung carcinoma (NSCLC) from small-cell lung carcinoma (SCLC). This non-invasive approach shows potential for accurate diagnosis in lung cancer patients.